Please use this identifier to cite or link to this item:
https://hdl.handle.net/11499/8763
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Açıkbaş, İbrahim | - |
dc.contributor.author | Şanlı, Berna | - |
dc.contributor.author | Tepeli, Emre | - |
dc.contributor.author | Ergin, Şeniz | - |
dc.contributor.author | Aktan, S. | - |
dc.contributor.author | Bağcı, Hüseyin | - |
dc.date.accessioned | 2019-08-16T12:46:34Z | - |
dc.date.available | 2019-08-16T12:46:34Z | - |
dc.date.issued | 2012 | - |
dc.identifier.issn | 1234-1010 | - |
dc.identifier.uri | https://hdl.handle.net/11499/8763 | - |
dc.identifier.uri | https://doi.org/10.12659/MSM.883544 | - |
dc.description.abstract | Background: Psoriasis is an inflammatory disease characterized by increased squamous cell proliferation and impaired differentiation. Vitamin D, Calcitriol, and its analogues are successfully used for psoriasis therapy. However, it is unknown why some psoriasis patients are resistant to Vitamin D therapy. Vitamin D mediates its activity by a nuclear receptor. It is suggested that polymorphisms and haplotypes in the VDR gene may explain the differences in response to vitamin D therapy. Material/Methods: In this study, 102 psoriasis patients and 102 healthy controls were studied for VDR gene polymorphisms. The Fok I, Bsm I, Apa I and Taq I polymorphisms were examined by PCR-RFLP, and 50 subjects received vitamin D therapy to evaluate the association between VDR gene polymorphisms and response to vitamin D therapy. Existence of cutting site is shown by capital letters, and lack was shown by lower case. The haplotypes were analysed by CHAPLIN. Results: There was significant difference in allele frequency of T and genotype frequency of Tt between cases and controls (p values 0.038 and 0.04, respectively). The Aa and bb genotypes were significantly higher in early onset than late onset psoriasis (p values 0.008 and 0.04, respectively). The genotypes Ff, ff and TT are significantly different between vitamin D3 therapy responders and non-responders (p values 0.04, 0.0001, 0.009, respectively). To the best of our knowledge, this is the first report showing importance of VDR gene haplotypes in psoriasis, the significance of the Wald and LR (Likelihood Ratio) statistics (p=0,0042) suggest that FfBbAatt is a disease-susceptibility haplotype. Conclusions: Haplotype analysis is a recent and commonly used method in genetic association studies. Our results reveal a previously unidentified susceptibility haplotype and indicate that certain haplotypes are important in the resistance to vitamin D3 therapy and the onset of psoriasis. The haplotypes can give valuable data where genotypes unable to do. © Med Sci Monit. | en_US |
dc.language.iso | en | en_US |
dc.publisher | International Scientific Literature Inc. | en_US |
dc.relation.ispartof | Medical Science Monitor | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Haplotype | en_US |
dc.subject | Polymorphism | en_US |
dc.subject | Psoriasis | en_US |
dc.subject | Turkish | en_US |
dc.subject | VDR | en_US |
dc.subject | Vitamin D | en_US |
dc.subject | calcipotriol | en_US |
dc.subject | vitamin D receptor | en_US |
dc.subject | adolescent | en_US |
dc.subject | adult | en_US |
dc.subject | aged | en_US |
dc.subject | arthralgia | en_US |
dc.subject | article | en_US |
dc.subject | child | en_US |
dc.subject | controlled study | en_US |
dc.subject | female | en_US |
dc.subject | gene frequency | en_US |
dc.subject | genetic association | en_US |
dc.subject | genotype | en_US |
dc.subject | haplotype | en_US |
dc.subject | human | en_US |
dc.subject | major clinical study | en_US |
dc.subject | male | en_US |
dc.subject | onset age | en_US |
dc.subject | polymerase chain reaction | en_US |
dc.subject | psoriasis | en_US |
dc.subject | restriction fragment length polymorphism | en_US |
dc.subject | school child | en_US |
dc.subject | treatment response | en_US |
dc.subject | Turkey (republic) | en_US |
dc.title | Vitamin D receptor gene polymorphisms and haplotypes (Apa I, Bsm I, Fok I, Taq I) in Turkish psoriasis patients | en_US |
dc.type | Article | en_US |
dc.identifier.volume | 18 | en_US |
dc.identifier.issue | 11 | en_US |
dc.identifier.startpage | CR661 | - |
dc.identifier.startpage | CR661 | en_US |
dc.identifier.endpage | CR666 | en_US |
dc.authorid | 0000-0001-7483-1147 | - |
dc.authorid | 0000-0002-7119-0302 | - |
dc.authorid | 0000-0003-0426-6685 | - |
dc.identifier.doi | 10.12659/MSM.883544 | - |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.identifier.pmid | 23111742 | en_US |
dc.identifier.scopus | 2-s2.0-84868594450 | en_US |
dc.identifier.wos | WOS:000314393900017 | en_US |
dc.identifier.scopusquality | Q2 | - |
dc.owner | Pamukkale University | - |
item.grantfulltext | open | - |
item.fulltext | With Fulltext | - |
item.cerifentitytype | Publications | - |
item.openairetype | Article | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.languageiso639-1 | en | - |
crisitem.author.dept | 14.03. Basic Medical Sciences | - |
crisitem.author.dept | 01.05. Health Research Center Managment | - |
crisitem.author.dept | 14.02. Internal Medicine | - |
crisitem.author.dept | 14.02. Internal Medicine | - |
crisitem.author.dept | 14.02. Internal Medicine | - |
crisitem.author.dept | 01. Pamukkale University | - |
Appears in Collections: | PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection Tıp Fakültesi Koleksiyonu WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
Files in This Item:
File | Size | Format | |
---|---|---|---|
10.12659 MSM.883544.pdf | 248.3 kB | Adobe PDF | View/Open |
CORE Recommender
SCOPUSTM
Citations
23
checked on Nov 16, 2024
WEB OF SCIENCETM
Citations
18
checked on Nov 21, 2024
Page view(s)
66
checked on Aug 24, 2024
Download(s)
30
checked on Aug 24, 2024
Google ScholarTM
Check
Altmetric
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.